CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 54

Industry reads hand-picked by our editors

Mar 11, 2024

The Washington Post
Brazil’s staggering dengue fever crisis is a warning to the world
The Financial Times
Novo Nordisk chief seeks more deals to cement weight-loss lead amid ‘hype’
Science
‘I’m never going to be Tony’: Jeanne Marrazzo, Anthony Fauci’s successor, vows a new direction at NIAID
The Atlantic
The Cystic-Fibrosis Breakthrough That Changed Everything

Mar 08, 2024

Associated Press
Weight-loss drugs like Wegovy are meant for long-term use. Some patients want to stop
Fierce Biotech
Tau, anti-inflammation and orals form Biogen’s future Alzheimer’s pipeline
NPR
‘All of Us’ research project diversifies the storehouse of genetic knowledge

Mar 07, 2024

The Atlantic
The Science Behind Ozempic Was Wrong
Time
What Happened When a Man Got 217 COVID-19 Vaccines
Nature
Trump versus Biden: what the rematch could mean for three key science issues

Mar 06, 2024

NPR
With a million cases of dengue so far this year, Brazil is in a state of emergency
Reuters
AstraZeneca to invest 650 million pounds in UK to boost ‘pandemic preparedness’
Nature
After obesity drugs’ success, companies rush to preserve skeletal muscle

Mar 05, 2024

Forbes
Does Federally Funded Research Justify A Piece Of Pharma’s Profits?
The Wall Street Journal
Novo Nordisk Says Ozempic Drug Cuts Risk of Kidney Problems
Politico
White House turns to health care in Biden’s latest move against ‘corporate greed’

Mar 04, 2024

Bloomberg
The Dirty Business of Monkey Laundering
Axios
Weight-loss drug restrictions shine spotlight on imbalance in obesity care
The Boston Globe
‘It’s a nightmare’: One of the most common children’s asthma meds is no longer available, leaving families scrambling

Mar 01, 2024

Bloomberg
Obesity Drugs Won’t Solve Problem That Affects 1 Billion People, WHO Warns
Financial Times
Lab monkey prices plunge in China as drug research slows
Science
‘A tough experience.’ Why would a scientist serve as an expert witness?

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
Overcoming Data Overload — How AI and Modernization are Transforming Biopharma Custom content for Endava
Playbook
Navigating New Opportunities in China's Pharmaceutical Boom Custom content for Evaluate
Trendline
Inside the world of cell therapies Supported by 10x Genomics

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Built for the Storm: Why Prepared Systems Win in Pharma Webinar - on demand • Provided by Phase2
4 major trends shaping today’s oncology market Webinar - on demand • Provided by Advisory Board
Trends and Innovations in Life Science Qualitative Research Webinar - on demand • Provided by Konovo

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.